1. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis
- Author
-
Kalafat, Erkan (ORCID 0000-0003-0658-138X & YÖK ID 197389), Smith, Emily R.; Oakley, Erin; Grandner, Gargi Wable; Ferguson, Kacey; Farooq, Fouzia; Afshar, Yalda; Ahlberg, Mia; Ahmadzia, Homa; Akelo, Victor; Aldrovandi, Grace; Barr, Beth A. Tippett; Bevilacqua, Elisa; Brandt, Justin S.; Broutet, Nathalie; Buhigas, Irene Fernandez; Carrillo, Jorge; Clifton, Rebecca; Conry, Jeanne; Cosmi, Erich; Crispi, Fatima; Crovetto, Francesca; Delgado-Lopez, Camille; Divakar, Hema; Driscoll, Amanda J.; Favre, Guillaume; Flaherman, Valerie J.; Gale, Chris; Gil, Maria M.; Gottlieb, Sami L.; Gratacos, Eduard; Hernandez, Olivia; Jones, Stephanie; Khagayi, Sammy; Knight, Marian; Kotloff, Karen; Lanzone, Antonio; Le Doare, Kirsty; Lees, Christoph; Litman, Ethan; Lokken, Erica M.; Laurita Longo, Valentina; Madhi, Shabir A.; Magee, Laura A.; Martinez-Portilla, Raigam Jafet; McClure, Elizabeth M.; Metz, Tori D.; Miller, Emily S.; Money, Deborah; Moungmaithong, Sakita; Mullins, Edward; Nachega, Jean B.; Nunes, Marta C.; Onyango, Dickens; Panchaud, Alice; Poon, Liona C.; Raiten, Daniel; Regan, Lesley; Rukundo, Gordon; Sahota, Daljit; Sakowicz, Allie; Sanin-Blair, Jose; Soderling, Jonas; Stephansson, Olof; Temmerman, Marleen; Thorson, Anna; Tolosa, Jorge E.; Townson, Julia; Valencia-Prado, Miguel; Visentin, Silvia; von Dadelszen, Peter; Waldorf, Kristina Adams; Whitehead, Clare; Yassa, Murat; Tielsch, Jim M., School of Medicine, Kalafat, Erkan (ORCID 0000-0003-0658-138X & YÖK ID 197389), Smith, Emily R.; Oakley, Erin; Grandner, Gargi Wable; Ferguson, Kacey; Farooq, Fouzia; Afshar, Yalda; Ahlberg, Mia; Ahmadzia, Homa; Akelo, Victor; Aldrovandi, Grace; Barr, Beth A. Tippett; Bevilacqua, Elisa; Brandt, Justin S.; Broutet, Nathalie; Buhigas, Irene Fernandez; Carrillo, Jorge; Clifton, Rebecca; Conry, Jeanne; Cosmi, Erich; Crispi, Fatima; Crovetto, Francesca; Delgado-Lopez, Camille; Divakar, Hema; Driscoll, Amanda J.; Favre, Guillaume; Flaherman, Valerie J.; Gale, Chris; Gil, Maria M.; Gottlieb, Sami L.; Gratacos, Eduard; Hernandez, Olivia; Jones, Stephanie; Khagayi, Sammy; Knight, Marian; Kotloff, Karen; Lanzone, Antonio; Le Doare, Kirsty; Lees, Christoph; Litman, Ethan; Lokken, Erica M.; Laurita Longo, Valentina; Madhi, Shabir A.; Magee, Laura A.; Martinez-Portilla, Raigam Jafet; McClure, Elizabeth M.; Metz, Tori D.; Miller, Emily S.; Money, Deborah; Moungmaithong, Sakita; Mullins, Edward; Nachega, Jean B.; Nunes, Marta C.; Onyango, Dickens; Panchaud, Alice; Poon, Liona C.; Raiten, Daniel; Regan, Lesley; Rukundo, Gordon; Sahota, Daljit; Sakowicz, Allie; Sanin-Blair, Jose; Soderling, Jonas; Stephansson, Olof; Temmerman, Marleen; Thorson, Anna; Tolosa, Jorge E.; Townson, Julia; Valencia-Prado, Miguel; Visentin, Silvia; von Dadelszen, Peter; Waldorf, Kristina Adams; Whitehead, Clare; Yassa, Murat; Tielsch, Jim M., and School of Medicine
- Abstract
Introduction: despite a growing body of research on the risks of SARS-CoV-2 infection during pregnancy, there is continued controversy given heterogeneity in the quality and design of published studies. Methods: we screened ongoing studies in our sequential, prospective meta-analysis. We pooled individual participant data to estimate the absolute and relative risk (RR) of adverse outcomes among pregnant women with SARS-CoV-2 infection, compared with confirmed negative pregnancies. We evaluated the risk of bias using a modified Newcastle-Ottawa Scale. Results: we screened 137 studies and included 12 studies in 12 countries involving 13 136 pregnant women. Pregnant women with SARS-CoV-2 infection-as compared with uninfected pregnant women-were at significantly increased risk of maternal mortality (10 studies; n=1490; RR 7.68, 95% CI 1.70 to 34.61); admission to intensive care unit (8 studies; n=6660; RR 3.81, 95% CI 2.03 to 7.17); receiving mechanical ventilation (7 studies; n=4887; RR 15.23, 95% CI 4.32 to 53.71); receiving any critical care (7 studies; n=4735; RR 5.48, 95% CI 2.57 to 11.72); and being diagnosed with pneumonia (6 studies; n=4573; RR 23.46, 95% CI 3.03 to 181.39) and thromboembolic disease (8 studies; n=5146; RR 5.50, 95% CI 1.12 to 27.12). Neonates born to women with SARS-CoV-2 infection were more likely to be admitted to a neonatal care unit after birth (7 studies; n=7637; RR 1.86, 95% CI 1.12 to 3.08); be born preterm (7 studies; n=6233; RR 1.71, 95% CI 1.28 to 2.29) or moderately preterm (7 studies; n=6071; RR 2.92, 95% CI 1.88 to 4.54); and to be born low birth weight (12 studies; n=11 930; RR 1.19, 95% CI 1.02 to 1.40). Infection was not linked to stillbirth. Studies were generally at low or moderate risk of bias. Conclusions: this analysis indicates that SARS-CoV-2 infection at any time during pregnancy increases the risk of maternal death, severe maternal morbidities and neonatal morbidity, but not stillbirth or intrauterine growth restriction, Funded by the Bill & Melinda Gates Foundation grant to ERS (INV- 022057).
- Published
- 2023